Skip to content

The effect of aquatic exercise on endocrine and hematological indices of children with autism spectrum disorder.

Studying the effect of aquatic exercise on endocrine indices, renal and hepatic enzymes, and hematological indices in children with autism spectrum disorder taking risperidone

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180503039517N14
Enrollment
40
Registered
2025-04-10
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder. Autistic disorder

Interventions

Intervention 1: Intervention group: Children in the aquatic exercise group will be examined by a physician to obtain permission to participate in the training sessions and will participate in water ex

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
8 Years to 14 Years

Inclusion criteria

Inclusion criteria: Gender: Boy (8-14 years old) Having autism grade 1 and 2 (the diagnosis of autism severity will be made by a specialist psychologist according to the Gars-2 scale) Taking risperidone for at least one year to reduce behavioral or sleep problems in children

Exclusion criteria

Exclusion criteria: having cardiovascular, musculoskeletal, and metabolic diseases limiting physical activity

Design outcomes

Primary

MeasureTime frame
Insulin resistance indicators. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Blood samples were taken in two stages, 48 ??hours before and after 8 weeks of intervention, after a 12-hour overnight fast, in the amount of 10 cc of blood, in a sitting position, from the brachial vein.;Metabolic syndrome indicators. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Metabolic syndrome indicators including systolic and diastolic blood pressure, triglycerides, HDL, and waist-to-hip circumference are measured.

Secondary

MeasureTime frame
Liver enzymes. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Serum AST and ALT levels will be measured before and after the intervention with a photometric method by the Dialab Laboratory kit (Austrian -made).;Kidney function indicators. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Serum levels of urea, creatinine, and BAN indicators are measured before and after the intervention using Biotechnical Autoanalyzer (made in Italy).;Hematological indicators. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: White and red blood cells, hematocrit, and platelets will be measured using the Cell Counter (made of Japan).;Thyroid hormones. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Thyroid hormones including T3 and T4 will be measured using Immunoassay AIA 360 (Made in America).;Adipokines. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Adipokines including adiponectin, Leptin, Resistin, and Asprosin will be measured through Elisa using the Shanghai Sunteam Biotech (made of China).;Lipid profile. Timepoint: 48 hours before the intervention and 48 hours after 10 weeks of intervention. Method of measurement: Normal values of serum triglyceride, total cholesterol, LDL, and HDL levels will be measured through Photometry Method Using Pars azmoon kit (Made in Iran).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh AdibSaber

Islamic Azad University

adibsaberf@gmail.com+98 910 103 3889

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026